The REGULATE trial is a crucial, large-scale, randomized study designed to determine the optimal vasopressor (blood pressure medication) strategy for patients with severe traumatic brain injury (TBI).

The goal is to see how norepinephrine, vasopressin, and a combination of the two affect brain blood flow control and overall cardiovascular function.

REGULATE is the first adequately powered trial to systematically compare these vasopressor strategies in severe TBI.

The results are expected to provide the evidence needed to develop individualized vasopressor strategies that can better optimize both the brain’s blood flow control and the body’s cardiovascular performance, ultimately helping to minimize secondary brain injury and improve neurological recovery.

Read More